CEO Mr Srimal is a leading industry executive professional with an extensive background in the pharmaceutical industry. He has led LPC Pharmaceuticals to new heights in growth and profitability. The company is examining exit opportunities for the owners and Mr Srimal has started the process for the exciting new project, Target Pharma UK Ltd.

COO Mr Shah is an accomplished pharmaceutical executive with operational responsibilities including regulatory, quality assurance and control, manufacturing, license and corporate development and extensive project management experience. He has identified the projected pharmaceutical license targets for Target's market entry as has worked in developing the Company's intended partners in quality compliance, manufacturing, and distribution.

Non-executive Director
Mr. Sexauer has been involved in the medical technology industry since 1979 and has served in expanding executive corporate positions. In 2006, he formed InterMark Associates Ltd., a London based consulting organization focused on the regenerative bio pharmaceutical medicine industry. Among projects undertaken included a turn around as CEO of Telomolecular Corporation, a CA based Nanotechnology Company that resulted in a